logo
South African rand shrugs off weak manufacturing data

South African rand shrugs off weak manufacturing data

Reuters2 days ago

JOHANNESBURG, June 10 (Reuters) - The South African rand strengthened on Tuesday despite a sharp contraction in local manufacturing output, as investors waited for more clarity on U.S.-China trade talks.
At 1415 GMT, the rand traded at 17.69 against the dollar , about 0.2% stronger than Monday's closing level.
South Africa's manufacturing output (ZAMAN=ECI), opens new tab fell 6.3% year on year in April, the sixth consecutive monthly decline, statistics agency data showed on Tuesday.
Analysts polled by Reuters had expected a drop of 3.9%.
Weakness in the manufacturing sector was one factor behind the first quarter's sluggish growth of just 0.1%(ZAGDPN=ECI), opens new tab, offsetting a strong performance by agriculture.
The rand was also supported on Tuesday by a stronger global gold price and by a weaker U.S. dollar .
The Johannesburg Stock Exchange's Top-40 index (.JTOPI), opens new tab was last up 0.6%. The benchmark 2035 government bond was stronger, as the yield fell 4 basis points to 10.095%.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Short-seller Chanos questions bitcoin-holding pioneer Strategy's valuation premium
Short-seller Chanos questions bitcoin-holding pioneer Strategy's valuation premium

Reuters

timean hour ago

  • Reuters

Short-seller Chanos questions bitcoin-holding pioneer Strategy's valuation premium

June 12 (Reuters) - Prominent short-seller Jim Chanos has questioned Strategy's (MSTR.O), opens new tab valuation premium over its bitcoin holdings, saying Chairman Michael Saylor's tactics to boost the company's returns are "financial gibberish." "...Mr. Saylor wants you to value his business based not only on the net value of his Bitcoin holdings (NAV) at market, but additionally with a multiple on the change in that NAV...," he said in a post on X on Tuesday. Also, in an interview with Bloomberg Television on Wednesday, Chanos said that Strategy's market value should not exceed the value of its bitcoin holdings. As of June 9, the company held 582,000 bitcoins, worth $62.27 billion, while its market value of $108 billion was about 1.74 times its crypto holdings. Chanos and other Strategy critics have argued that this disconnect was creating an arbitrage opportunity for buying the cryptocurrency and shorting the firm's shares. Strategy did not immediately respond to a Reuters request for comment. Following Strategy's footsteps, companies like GameStop (GME.N), opens new tab and U.S. President Donald Trump's Trump Media & Technology (DJT.O), opens new tab have also pivoted their operations to building bitcoin reserves. Strategy's shares are up nearly 34% this year, eclipsing bitcoin's 14.2% climb. Saylor has argued that critics overlook his company's innovative use of bitcoin-backed financial instruments, which he insists justify the premium at which the company trades and protect it from the risks Chanos highlights. The company actively issues bitcoin-backed credit instruments, such as non-cumulative preferred stock, allowing it to raise capital without diluting common shareholders or taking on traditional debt obligations.

One Cycling project not included in next season's UCI calendar
One Cycling project not included in next season's UCI calendar

Reuters

timean hour ago

  • Reuters

One Cycling project not included in next season's UCI calendar

June 12 (Reuters) - The UCI opted not to include the One Cycling project when it launched its World Tour and Women's World Tour calendars for 2026 on Thursday, with the governing body saying it was incompatible with its regulatory framework. The project, reportedly backed by an investment firm owned by Saudi Arabia's Public Investment Fund (PIF), aims to revolutionise cycling with the support of major teams and race organisers. One Cycling wanted an overhaul of the calendar and the possible creation of new competitions to generate new sources of revenue. "The project, which had been developed by certain teams and organisers in collaboration with a sports investment fund, was deemed incompatible with the governance and regulatory framework of the UCI as well as lacking sporting coherence," a UCI press release said. The UCI said it welcomed the fact that cycling is attracting new investors and wished to continue discussions with the project's representatives. There is one addition to the women's calendar with the Dwars door Vlaanderen on April 1, after the race had previously been run on the UCI ProSeries calendar, the second-tier tour. In an effort to promote the continued development of women's cycling, the UCI Management Committee approved a 20% increase in the participation allowance paid by organisers of Women's World Tour events to participating teams.

Kenvue mulls sale of some skin health and beauty brands, sources say
Kenvue mulls sale of some skin health and beauty brands, sources say

Reuters

timean hour ago

  • Reuters

Kenvue mulls sale of some skin health and beauty brands, sources say

NEW YORK, June 12 (Reuters) - Kenvue (KVUE.N), opens new tab is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on Thursday, as the consumer health firm prunes an underperforming business segment to focus on core products. The company, which was spun out of Johnson & Johnson (JNJ.N), opens new tab in 2023, is zeroing in on smaller brands in the unit to sell such as Clean & Clear, Maui Moisture, Neostrata, its German baby care brand Bebe, and Japanese brand the sources said. It plans to hold onto the bigger names in the unit, such as Neutrogena and Aveeno, the sources said. There are about a dozen brands in the skin health and beauty unit, and sources cautioned that the divestiture package could change and no deal was guaranteed. Investment bankers at Goldman Sachs (GS.N), opens new tab are working with Kenvue on the divestment process, they added. Kenvue and Goldman declined to comment. The around half-dozen brands earmarked for sale would generate more than $500 million of revenue together, two of the sources said, a small portion of Kenvue's overall revenue, which was $15.5 billion in 2024. The skin health and beauty unit has been a drag on Kenvue's earnings, but the company has dedicated more money to marketing, especially on Neutrogena ad campaigns. The unit's organic sales declined 4.8% year-over-year in Kenvue's latest quarter that ended March 30. Kenvue, which also makes Tylenol and Band-Aids, has faced activist pressure over the last year from Starboard Value, Toms Capital Management and Third Point. It settled with Starboard in March, when it added the investment firm's founder to its board. Some of the activists have been pushing the company to consider selling itself or certain brands. In May, the company brought on new Chief Financial Officer Amit Banati from Kellanova(K.N), opens new tab , Kellogg's spun-out snacking unit.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store